These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying. Booysen E; Bezuidenhout M; van Staden ADP; Dimitrov D; Deane SM; Dicks LMT Probiotics Antimicrob Proteins; 2019 Mar; 11(1):310-316. PubMed ID: 29961212 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections. Arayici PP; Coksu I; Ozbek T; Acar S Biomater Adv; 2024 Jul; 161():213862. PubMed ID: 38678666 [TBL] [Abstract][Full Text] [Related]
6. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus. Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680 [TBL] [Abstract][Full Text] [Related]
7. Presence of multiple van genes among glycopeptide non-susceptible Staphylococcus aureus exhibiting in vitro MIC creep phenomenon: A study from north-east India. Hazarika M; Nath K; Bhowmik D; Singha KM; Dhar D; Bhattacharjee A Indian J Med Res; 2024 Jul; 160(1):109-117. PubMed ID: 39382498 [TBL] [Abstract][Full Text] [Related]
8. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India. Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814 [TBL] [Abstract][Full Text] [Related]
9. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. Tiwari HK; Sen MR BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393 [TBL] [Abstract][Full Text] [Related]
10. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study]. Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824 [TBL] [Abstract][Full Text] [Related]
11. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium. Odenholt I; Löwdin E; Cars O Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681 [TBL] [Abstract][Full Text] [Related]
12. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999]. Nashev D; Toshkova K; Gavrilova V Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664 [TBL] [Abstract][Full Text] [Related]
13. [Investigation of the Antibacterial Synergistic Activity of Fosfomycin-Teicoplanin Combination in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Various Clinical Sample]. Biçer RT; Özekinci T; Koçoğlu ME Mikrobiyol Bul; 2024 Apr; 58(2):113-124. PubMed ID: 38676580 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881 [TBL] [Abstract][Full Text] [Related]
16. Glycopeptide intermediate Staphylococcus aureus and prevalence of the luk-PV gene in clinical isolates, in Northern Lebanon. El Ayoubi MD; Hamze M; Mallat H; Achkar M; Dabboussi F Med Mal Infect; 2014 May; 44(5):223-8. PubMed ID: 24835167 [TBL] [Abstract][Full Text] [Related]
17. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections. Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313 [TBL] [Abstract][Full Text] [Related]
18. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. Shibl AM; Ishag AH; Durgham SM APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of methicillin-resistant Qiu Y; Wu Y; Lu B; Zhu G; Gong T; Wang R; Peng Q; Li Y Biofouling; 2020 Feb; 36(2):159-168. PubMed ID: 32182142 [TBL] [Abstract][Full Text] [Related]
20. Draft genome sequences of three clinical isolates of teicoplanin-resistant Staphylococcus epidermidis from patients without prior exposure to glycopeptide antibiotics. Vimberg V; Zieglerova L; Závora J; Šemberová L; Prásilová J; Adámková V; Novotna GB J Glob Antimicrob Resist; 2019 Mar; 16():251-253. PubMed ID: 30797086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]